The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived ames dwarf mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65, Issue 1, 2010, Pages 24-30

  Masternak, Michal M ^a   Panici, Jacob A ^a   Wang, Feiya ^a   Wang, Zhihui ^a,b   Spong, Adam ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Aging; Ames dwarf; Growth hormone; Insulin

Indexed keywords

ANIMALIA; MUS;

GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; INSULIN RESISTANCE; LONGEVITY; MALE; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PITUITARY DWARFISM; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DWARFISM, PITUITARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MALE; MICE; MICE, MUTANT STRAINS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 74049114051     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp172     Document Type: Article

References (33)

1. DeFronzo RA. Glucose intolerance and aging. Diabetes Care. 1981; 4(4):493-501.
2. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentra-tions in man. Diabetologia. 1985;28(7):412-419. (Pubitemid 15018832)
3. Barbieri M, Rizzo MR, Manzella D, et al. Glucose regulation and oxidative stress in healthy centenarians. Exp Gerontol. 2003;38(1-2): 137-143. (Pubitemid 36113262)
4. Bartke A. Insulin and aging. Cell Cycle. 2008;7(21):3338-3343.
5. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science. 2003;299(5611):1346-1351. (Pubitemid 36254639)
6. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384(6604):33.
7. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J Endo-crinol. 2002;173(1):81-94. (Pubitemid 34428894)
8. Masternak MM, Panici JA, Bonkowski MS, Hughes LF, Bartke A. Insulin sensitivity as a key mediator of growth hormone actions on longevity. J Gerontol A Biol Sci Med Sci. 2009;64(5):516-521.
9. Weindruch R, Walford R. The Retardation of Aging and Disease by Dietary Restriction. Springfi eld, IL: Thomas; 1988.
10. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Dea-coness Medical Center. Caloric intake and aging. N Engl J Med 1997;337(14):986-994.
11. Bartke A, Wright JC, Mattison JA, Ingram DK, Miller RA, Roth G S Extending the lifespan of long-lived mice. Nature. 2001;414(6862):412. (Pubitemid 34173717)
12. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology. 2000;141(7):2608-2613. (Pubitemid 32269083)
13. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hor-mone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinol-ogy. 2003;144(9):3799-3810. (Pubitemid 37088732)
14. Shimokawa I, Higami Y, Utsuyama M, et al. Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathol. 2002;160(6):2259-2265. (Pubitemid 34663416)
15. Shimokawa I, Chiba T, Yamaza H, Komatsu T. Longevity genes: in-sights from calorie restriction and genetic longevity models. Mol Cells. 2008;26(5):427-435.
16. Carter CS, Ramsey MM, Ingram RL, et al. Models of growth hormone and IGF-1 defi ciency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci Med Sci. 2002;57(5): B177-B188.
17. Fintini D, Alba M, Salvatori R. Infl uence of estrogen administration on the growth response to growth hormone (GH) in GH-defi cient mice. Exp Biol Med (Maywood). 2005;230(10):715-720. (Pubitemid 41565940)
18. Vergara M, Smith-Wheelock M, Harper JM, Sigler R, Miller RA. Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant. J Gerontol A Biol Sci Med Sci. 2004; 59(12):1244-1250. (Pubitemid 40209410)
19. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric re-striction. Endocrinology. 2005;146(2):851-860. (Pubitemid 40129843)
20. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002;288(18):2282-2292. (Pubitemid 35291758)
21. de ZF, Ong K, van HM, Mohn A, Woods K, Dunger D. High-dose growth hormone (GH) treatment in non-GH-defi cient children born small for gestational age induces growth responses related to pretreat-ment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab. 2002;87(1):148-151. (Pubitemid 34084684)
22. Norrelund H, Djurhuus C, Jorgensen JO, et al. Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol Endocrinol Metab. 2003;285(4): E737-E743. (Pubitemid 37176424)
23. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and geno-type: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci. 2008;63(5):447-453.
24. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC, Tam S. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J Clin Endocrinol Metab. 2004;89(11):5448-5453. (Pubitemid 39518424)
25. Balbis A, Dellacha JM, Calandra RS, Bartke A, Turyn D. Down regu-lation of masked and unmasked insulin receptors in the liver of trans-genic mice expressing bovine growth hormone gene. Life Sci. 1992; 51(10):771-778.
26. Balbis A, Bartke A, Turyn D. Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci. 1996;59(16): 1363-1371. (Pubitemid 26344589)
27. Dominici FP, Cifone D, Bartke A, Turyn D. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am J Physiol. 1999;277(3, pt 1):E447-E454. (Pubitemid 29458204)
28. Davidson MB, Melmed S. Hepatocyte insulin binding and action in rats with somatomammotrophic tumours. Diabetologia. 1983;25(1): 60-65. (Pubitemid 13070131)
29. Dominici FP, Turyn D. Growth hormone-induced alterations in the insulin-signaling system. Exp Biol Med (Maywood). 2002 ; 227 (3): 149-157.
30. Bonkowski MS, Dominici FP, Arum O, et al. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity. PLoS One. 2009;4(2):e4567.
31. Sharp ZD, Bartke A. Evidence for down-regulation of phosphoinosit-ide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2005;60(3):293-300. (Pubitemid 40628792)
32. Panici JA, Wang F, Bonkowski MS, et al. Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans? J Gerontol A Biol Sci Med Sci. 2009;64A:1126-1133.
33. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-395.